Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Suzuken Co., Ltd. (SZUKF)

Compare
30.30
0.00
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
2,386,493,000
2,386,493,000
2,314,828,000
2,239,112,000
2,128,478,000
Cost of Revenue
2,201,244,000
2,201,244,000
2,135,133,000
2,071,780,000
1,970,637,000
Gross Profit
185,249,000
185,249,000
179,694,000
167,332,000
157,840,000
Operating Expense
150,373,000
150,373,000
147,089,000
147,216,000
148,683,000
Operating Income
34,876,000
34,876,000
32,605,000
20,116,000
9,157,000
Net Non Operating Interest Income Expense
123,000
123,000
129,000
145,000
118,000
Pretax Income
42,793,000
42,793,000
30,594,000
22,484,000
12,557,000
Tax Provision
13,793,000
13,793,000
10,275,000
8,012,000
4,559,000
Net Income Common Stockholders
29,016,000
29,016,000
20,345,000
14,393,000
7,895,000
Diluted NI Available to Com Stockholders
29,016,000
29,016,000
20,345,000
14,393,000
7,895,000
Basic EPS
357.88
--
236.47
163.19
88.52
Diluted EPS
357.88
--
236.47
163.19
88.52
Basic Average Shares
81,079.05
--
86,039.27
88,203
89,194
Diluted Average Shares
81,079.05
--
86,039.27
88,203
89,194
Total Operating Income as Reported
34,875,000
34,875,000
32,605,000
20,116,000
9,156,000
Total Expenses
2,351,617,000
2,351,617,000
2,282,222,000
2,218,996,000
2,119,320,000
Net Income from Continuing & Discontinued Operation
29,016,000
29,016,000
20,345,000
14,393,000
7,895,000
Normalized Income
26,004,324
26,004,324
24,183,584
14,992,564
11,534,818
Interest Income
166,000
166,000
171,000
196,000
167,000
Interest Expense
43,000
43,000
42,000
51,000
49,000
Net Interest Income
123,000
123,000
129,000
145,000
118,000
EBIT
42,836,000
42,836,000
30,636,000
22,535,000
12,606,000
EBITDA
51,399,000
51,399,000
39,275,000
32,095,000
22,785,000
Reconciled Cost of Revenue
2,201,244,000
2,201,244,000
2,135,133,000
2,071,780,000
1,970,637,000
Reconciled Depreciation
8,563,000
8,563,000
8,639,000
9,560,000
10,179,000
Net Income from Continuing Operation Net Minority Interest
29,016,000
29,016,000
20,345,000
14,393,000
7,895,000
Total Unusual Items Excluding Goodwill
4,442,000
4,442,000
-5,781,000
-931,000
-5,714,000
Total Unusual Items
4,442,000
4,442,000
-5,781,000
-931,000
-5,714,000
Normalized EBITDA
46,957,000
46,957,000
45,056,000
33,026,000
28,499,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,430,324
1,430,324
-1,942,416
-331,436
-2,074,182
3/31/2021 - 9/10/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EBOSF EBOS Group Limited
20.50
0.00%
 
MEPDF MediPal Holdings Corporation
14.75
0.00%
 
GZPHF Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
2.3700
0.00%
 
AMFPF Amplifon S.p.A.
22.00
0.00%
 
SHPMF Shanghai Pharmaceuticals Holding Co., Ltd
1.5620
0.00%
 
GALNF Galenica AG
75.25
0.00%
 
ARHCF Alfresa Holdings Corporation
11.87
0.00%
 
SHTDY Sinopharm Group Co. Ltd.
11.31
-1.09%
 
HSIC Henry Schein, Inc.
65.47
-1.68%
 
COR Cencora, Inc.
278.39
-3.79%